Begin main content

Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: Clinical Effectiveness

Last updated: October 30, 2017
Project Number: RB1151-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of the off-label use of intravenous immunoglobulin for the treatment of neurological or neuromuscular conditions?

Key Message

Sixteen systematic reviews (five with meta-analyses), 10 randomized controlled trials, and seven non-randomized studies were identified regarding the clinical effectiveness of off-label use of intravenous immunoglobulin for the treatment of neurological or neuromuscular conditions.